Streetbeat News

Products Services

JNJ

JNJ's Anssen has submitted a supplemental Biologics License Application to the U.S. FDA, seeking approval for CARVYKTI to treat patients with relapsed or refractory multiple myeloma at an earlier stage.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:32 pm

LEGN

Legend Biotech has submitted a supplemental application to the FDA for the expanded use of CARVYKTI, a cancer treatment drug.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:31 pm

AAPL

Apple's stock has historically experienced a dip in the month following major product announcements, such as the iPhone, MacBook, and iPad. The recent release of the Vision Pro augmented/virtual reality headset has also led to a 2% decline in Apple shares.

Portfolio Pulse from Piero Cingari

June 06, 2023 | 8:25 pm

LIAN

LianBio reports positive topline results from Phase 2a trial of infigratinib in Chinese patients with gastric cancer and gastroesophageal junction adenocarcinoma, with a confirmed ORR of 25.0%. The China NMPA granted Breakthrough Therapy Designation to infigratinib.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:11 pm

RNAZ

TransCode Therapeutics has announced positive preclinical results for its lead candidate TTX-MC138 in treating glioblastoma. The company's stock, RNAZ, may be impacted by this news.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:10 pm

ONCT

Oncternal Therapeutics has dosed the first patient in a Phase 1/2 study of ONCT-808, a ROR1 targeting autologous CAR T cell therapy for relapsed or refractory aggressive B-cell lymphoma. Initial clinical data is expected in late 2023, with additional readouts in 2024.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:04 pm

MSFT

Microsoft's Xbox Marketing VP Aaron Greenberg announced that the upcoming Xbox Showcase will feature authentic game footage, with no reliance on full CG trailers. The company will also not adhere to the previous rule of showcasing only games set to release within 12 months.

Portfolio Pulse from Franca Quarneti

June 06, 2023 | 7:57 pm

HLTH

Cue Health (NASDAQ:HLTH) has received De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for home and point-of-care use. This marks the first FDA De Novo authorization for a home use COVID-19 test and the first for any home use respiratory test.

Portfolio Pulse from Charles Gross

June 06, 2023 | 7:54 pm

FSR

Fisker announced it will begin US deliveries of its all-electric Fisker Ocean SUV later this month and has agreed to sell emission credits to a major automaker at competitive rates.

Portfolio Pulse from Charles Gross

June 06, 2023 | 7:40 pm

LEGN

Legend Biotech announced positive results from the Phase 3 CARTITUDE-4 study, showing cilta-cel reduced the risk of disease progression or death by 74% in multiple myeloma patients. HC Wainwright analyst reiterated a Buy rating and increased the price target from $77 to $82.

Portfolio Pulse from Vandana Singh

June 06, 2023 | 7:19 pm